NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Triumph Financial, Inc. (TFIN) Q4 2025 Earnings Call Transcript

First BanCorp. (FBP) Q4 2025 Earnings Call Transcript

Northwest Bancshares, Inc. (NWBI) Q4 2025 Earnings Call Transcript

U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs

Investors looking for stocks in the REIT and Equity Trust - Residential sector might want to consider either Safehold (SAFE) or American Homes 4 Rent (AMH). But which of these two stocks presents investors with the better value opportunity right now?

Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Cousins Properties (CUZ) and National Health Investors (NHI). But which of these two stocks offers value investors a better bang for their buck right now?

Investors with an interest in Shoes and Retail Apparel stocks have likely encountered both Adidas AG (ADDYY) and Nike (NKE). But which of these two stocks is more attractive to value investors?

Investors looking for stocks in the Automotive - Original Equipment sector might want to consider either Allison Transmission (ALSN) or Ferrari (RACE). But which of these two stocks is more attractive to value investors?

Investors with an interest in Financial - Investment Bank stocks have likely encountered both The Charles Schwab Corporation (SCHW) and Robinhood Markets, Inc. (HOOD). But which of these two companies is the best option for those looking for undervalued stocks?

Investors with an interest in Financial - Miscellaneous Services stocks have likely encountered both Virtu Financial (VIRT) and Moody's (MCO). But which of these two companies is the best option for those looking for undervalued stocks?

Investors looking for stocks in the REIT and Equity Trust sector might want to consider either Apollo Commerical Finance (ARI) or Ladder Capital (LADR). But which of these two stocks is more attractive to value investors?

Investors interested in stocks from the Manufacturing - Tools & Related Products sector have probably already heard of Stanley Black & Decker (SWK) and Lincoln Electric Holdings (LECO). But which of these two companies is the best option for those looking for undervalued stocks?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or Exact Sciences (EXAS). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?

Investors interested in Retail - Jewelry stocks are likely familiar with Signet (SIG) and Compagnie Financiere Richemont AG (CFRUY). But which of these two stocks offers value investors a better bang for their buck right now?

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

S&P Global earns a buy rating due to improved valuation and robust long-term compounding prospects. SPGI's forward P/E of 26.7x for 2026 is below its historical average, offering a margin of safety for quality growth. EPS is projected to grow 10–12% annually, supporting a potential 152% upside over 10 years if multiples remain stable.

I'm initiating Sandisk Corporation with a Buy pre-earnings due Thursday after the bell and see near-term momentum as AI-driven storage demand and supply constraints fuel upside. SNDK benefits from tight NAND supply, surging memory prices, and hyperscaler SSD demand, as AI storage needs remain underappreciated by the market. Valuation is stretched but in line with peers. SNDK's forward PEG of 0.34 and technicals remain supportive above key EMAs.